As of April 16, 2025, Immunome (IMNM) has a market cap of $0.64 billion USD. According to our data, Immunome is ranked No.5654 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.64 B |
-28.45%
|
Dec 31, 2024 | $0.90 B |
-0.75%
|
Dec 29, 2023 | $0.91 B |
384.16%
|
Dec 30, 2022 | $0.19 B |
-82.95%
|
Dec 31, 2021 | $1.10 B |
33.88%
|
Dec 31, 2020 | $0.82 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptive Biotechnologies
ADPT
|
$1.15 B |
0.000 M
|
![]() USA
|
![]() Vir Biotechnology
VIR
|
$0.77 B |
-0.000 M
|
![]() USA
|
![]() Twist Bioscience
TWST
|
$2.36 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
Market Cap | = | IMNM Stock Price | * | IMNM Shares Outstanding |
= | $7.40 | * | 86.95 M | |
= | $0.64 B |